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Introduction:
There is evidence that in selected high-risk individuals, low dose computed tomography (LDCT) screening significantly reduces lung cancer mortality and all-cause mortality and is recommended by many international organizations [1, 2] . However, as outlined by the recent Cochrane review, the relative harms and benefits of screening across different risk groups and settings needs to be considered and there is a requirement for standardized practices for screening with LDCT [3, 4] . The ACR Society of Thoracic Radiology suggests CT examinations should be acquired by using multidetector scanners with at least 16 detector rows, a helical technique, and with the patient in a suspended state of full inspiration [5] . For a standardized patient, it is recommended that the technique should deliver CTDIvol of To maximize the risk-benefit ratio in favor of the screened individual, the radiation dose should be as low as reasonably achievable without compromising image quality and accurate detection but the maximum extent of dose reduction has not yet been established.
The broad availability of iterative reconstruction algorithms on clinical CT scanners has enabled significant potential dose reduction in the context of screening. There are several versions of iterative reconstructions. The first generation (hybrid) shows dose reduction in the range of 30-40% [6] [7] [8] [9] [10] [11] . The second generation iterative reconstruction (pure) has shown more dose reduction capability with reported range of 50-80% compared to the traditional filtered-back projection (FBP) [12] [13] [14] [15] [16] [17] . Recent papers have explored the feasibility of using -based iterative reconstruction (MBIR) in the context of lung nodule surveillance [18] [19] [20] . It has been shown that it is possible to achieve meaningful image quality but significant dose reduction was achieved on selected patients with low body weight or BMI. In a western population, the average body weight/BMI are considerably higher. Currently, there are 2 broad strategies in performing LDCT with regards to setting of tube current. Investigators have used either tube current modulation approach or   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 a fixed tube current approach. It is not clear which methods are more reliable in real world setting where there is large variation in body size.
The purpose of our study is to determine the diagnostic accuracy of lung nodule detection in thoracic CT using 2 reduced dose protocols using automatic tube current modulation and fixed tube current approaches comparing 3 available CT reconstruction algorithms (filtered back projection-FBP, adaptive statistical reconstruction-ASIR and model-based iterative reconstruction-MBIR) to reference standard-dose thoracic CT in a western population.
Materials and Methods

Study Population
This prospective single-center study obtained institutional review board approval and recruited 98 patients. Patients were identified from referral to department for a non-contrast CT Thorax with a specific indication of follow-up of previously detected lung nodule(s) on a prior CT scan. The identified participants were interviewed and on agreement were prospectively enrolled consecutively from August 2013 February 2015. Written informed consent was obtained on all patients. We follow the previously published Fleischner society guidelines for follow-up of solitary pulmonary nodule [21, 22] .
Inclusion and Exclusion criteria
Inclusion criteria for the study were as follows: age more than or equal to 40 years of age at the time of scan, able to provide informed written consent, able to hold their breath for at least 20 seconds, able to follow verbal commands for breath holding and remain still for the duration of scanning, able to put arms over head for the entirety of the scan. Exclusion criteria were as follows: unable to give inform consent, other scan indication (e.g. with contrast, CT pulmonary angiogram, etc), unable to put hands over their head. Patient demographics (weight, height, and body mass index (calculated by weight / height in meters square) and clinical information (e.g. previous thoracic surgery, history of malignancy, clinical symptoms) were recorded.
Imaging Parameters
All examinations were performed with a 64-row detector CT scanner (Discovery 750 HD; GE Healthcare, Wisconsin, USA). No intravenous contrast was given. Standard dose scan parameters were as follows: tube voltage 120, rotation time 0.5s, pitch 1.375:1, noise index 39.6, tube current range 10-750mA. Reduced-dose 1 (RD1) scan parameters were as follows :   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 tube voltage 100, rotation time 0.5s, pitch 1.375:1, noise index 85, tube current range 10-750mA. Reduced-dose 2 (RD2) scan parameters were as follows: tube voltage 100, rotation time 0.5s, pitch 0.984:1, fixed tube current 10mA. All Patients were scanned in a single breath-hold.
Scanning Parameters
The order of 2 reduced dose scans were randomized after the initial standard of care scan to even out the effect of artefact that could inadvertently occur if the patient breathed during scanning. It is thought that this would be more likely to occur towards the end of the scan.
Block randomization method was used to maintain equal numbers in each arm.
Reconstruction Algorithms
All patients received 3 scans in total (STD, RD1 and RD2). Each scan was reconstructed with FBP, ASIR with 30% blending, and MBIR. For each patient, this generated 9 scans and for all patients this generated a total of 882 scans. For the purpose of assessment, standard dose with ASIR was used as reference standard because in our center this is in routine clinical use, and our standard dose protocol are already optimized for ASIR not FBP. The remaining scans and reconstruction algorithms serve as index tests under evaluation (see Figure 1 ).
Radiation Dose DLP and CTDIvol were recorded for each scanning series. AP and lateral diameters were recorded and by using the conversion factors as per American Association of Physicists Medicine (AAPM) guidelines, SSDE was calculated [23] . Effective doses (ED) were also estimated using a conversion of 0.014 taken from a normalized value of ED per DLP for chest [24] .
Objective Image Assessment
Quantitative measurements were performed using advanced open-source PACS workstation DICOM viewer (Osirix 3.8.1 on Mac OS, Pixmeo, Geneva, Switzerland) and GE (GE Healthcare, Wisconsin, USA) Workstations with dedicated Volume Viewer (v.4.6). Mean CT attenuation values (in Hounsfield units) and standard deviation were obtained in three consecutive images over the aorta by manually placing a circular region on interests (ROIs) which were duplicated to all 9 series. ROIs were copied to identical slices to allow for accurate comparison between different dose scans in the same patient at same location. For each study, the image noise was measured as the standard deviation of the pixel values drawn over the aorta. Signal to noise ratio was calculated by dividing mean HU by mean SD.
Subjective Image Assessment
All image data sets were assessed blinded and randomized manner by two experienced thoracic radiologists (5 and 8
. Mean scores were calculated for each of the reconstructed series. Subjective image quality were assessed in terms of subjective image noise, subjective image contrast, artifacts and diagnostic confidence.
Subjective analysis scoring criteria
Subjective image noise was assessed using a five-point scale (1 = unacceptable image noise, 2 = above average noise, 3 = average image noise, 4 = less than average noise, and 5 = minimal image noise).
Image contrast was assessed by using a five-point scale (1= very poor contrast, 2 = suboptimal image contrast, 3 = acceptable image contrast, 4 = above average contrast, and 5 = excellent image contrast).
Diagnostic confidence was assessed by using a four-point scale (1 = poor confidence, 2 = confident only for a limited clinical entity such as a calcified lesion, or a large lesion, 3 = probably confident, and 4 = completely confident). Scores for diagnostic confidence was used 
Results
Patient demographics are listed in Table 1 . There were 62 men and 38 women. Mean age was 66.2 (range 43-89). Mean BMI was 28.2 (± 6.5 SD). Radiation dose is listed in Table 2 . DLP were 235.5, 68.7 and 9.9 mGy.cm for STD, RD1 and RD2 respectively. SSDE were 7.4, 2.1 and 0.3 mGy for STD, RD1 and RD2 respectively.
Objective Image Assessment
There was significant difference between the measured noise across all reconstruction algorithms and dose. Compared to standard dose ASIR, FBP shows higher image noise, and MBIR shows lower image noise (p<0.05). This is tabulated in Table 3 . In terms of attenuation values, compared to standard dose ASIR, no significant difference exists between different doses and algorithms except for RD2 MBIR (p<0.05). This is tabulated in Table 4 .
We postulate that the reduced mean attenuation values for RD2 MBIR may be due to over correction of an otherwise noisy raw images obtained from very low dose scan. Table 5 . Interobserver agreement ranged from moderate to almost perfect (k= 0.54-0.81 for subjective image noise; k=0.65-0.89 for subjective image contrast; k= 0.54-0.89 for diagnostic confidence). Diagnostic confidence was further analyzed to identify studies that were deemed of diagnostic quality This shows that there is reduced diagnostic 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 acceptability for RD2, and to lesser extent RD1. The diagnostic acceptability was 100% for STD dose (FBP, ASIR, MBIR), RD1 (MBIR). This reduced to 98% for RD 1 (ASIR and FBP), 91.8% for RD2 (ASIR and MBIR, and most reduced to 85.7% for RD2 (FBP) . ) The reduced quality was correlated to patients with high BMI (see Figure 4 -5).
Diagnostic Accuracy AUC, sensitivity and specificity were calculated and overall detection accuracy is shown in Table 6 . Further sub-analysis based on lesion size for solid and subsolid nodules were also performed and is shown in Table 7 -8. The inter-observer agreement was almost perfect and was 0.971, 0.973 and 0.981 respectively for solid, subsolid and calcified nodules.
Solid Nodules:
-5.9mm: 36, 6-7.9mm: 25, 24). For solid nodules, excellent detection accuracy was maintained when using standard dose regardless of reconstruction algorithms with AUC >0.98 for both readers. For ASIR, AUC for RD1 was 0.977/0.963 and AUC for RD2 was 0.917/0.916, respectively for rater 1/rater2. For FBP, AUC for RD1 was 0.958/0.944 and AUC for RD2 was 0.856/0.841, respectively for rater 1/rater2. For MBIR, AUC for RD1 was 0.972/0.958 and AUC for RD2 was 0.921/0.916, respectively for rater 1/rater2. The detection of nodules were significantly impaired for nodules of <4mm (see Figure 6 ). This was markedly worse for RD2. For ASIR, AUC for RD1 was 0.935/0.913 and AUC for RD2 was 0.717/0.717, respectively for rater 1/rater2. For FBP, AUC for RD1 was 0.913/0.891 and AUC for RD2 was 0.609/0.587, respectively for rater 1/rater2. For MBIR, AUC for RD1 was 0.935/0.913 and AUC for RD2 was 0.739/0.739, respectively for rater 1/rater2. For nodules >4.1mm, detection accuracy was maintained at AUC > 0.95 in all cases except for FBP reconstruction of RD1 and RD2.
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Discussion
Diagnostic performance of lung nodule is affected by nodule size, protocol, reconstruction deterioration of RD2 is rela It is important to be aware that in pursuit of low dose, one must not compromise on diagnostic quality. Recent study in chest phantom examining detectability of lung nodule at chest radiograph equivalent dose has shown overall detection rates of 93.3% with DLP: 9mGy*cm [25] . Their detection rates for small 5mm solid nodules were 83.9 % using iterative reconstruction. The dose in this study was similar to our RD2 protocol dose. Our results demonstrate slightly poorer performance but this can be explained by the fact that we performed on real patients, many of whom have larger body size compared to the phantom model. Several previous studies have been performed using ultra low dose chest CT but has not been extensively tested [17, 18, 20, 26, 27] . It is known that iterative reconstruction may cause impairment in subjective image quality especially at very low doses [26] and is in line with our subjective analysis findings. In our study, the main focus was on the detection of nodules in a follow-up cohort. Inclinical practice, one must be acutely aware of the effect of on detection accuracy. For both reduced dose approaches, we have shown that there are limits to how far once can reduce the dose. The diagnostic acceptability for nodule detection subjectively was reduced when tube current modulation approach was used at BMI > 52, whereas for the fixed approach this was at BMI > 38. This is further confirmed when loss of nodule detection was further subclassified based on BMI. These BMIs appear to be the rough estimation of ceiling limits for both approaches in our study, but it must be noted that only small number of patients were scanned in our study with high BMI (BMI>50: n=2; BMI>38: n=8). Further studies with more patients at high BMI range will be required to respectively for each rater. So even for centers without the latest pure iterative reconstruction, one may still be able to achieve significant dose reduction without significant compromise on accuracy. It is important to be aware of the limit of detection accuracy in a technique and clinical indication of a test will determine the level at which one can afford to set a threshold limit. In the context of pulmonary nodule follow-up for suspected pulmonary metastasis in patients who has a history of malignancy, accurate detection is needed regardless of size, as detection no matter how small is likely to lead to change in management. In the context of lung cancer screening, there is now increasing evidence that detection of nodules < 5mm for example from the NELSON trial, no follow up is needed as these nodules are not predictive of lung cancer with low probability similar to individuals without nodules [29] . Therefore in this context, one may rightly choose to obviate the need for detection of small clinically irrelevant nodules.
There are several limitations in our study. First, our gold standard is nodule detected on standard dose ASIR. We have no pathological proof of clinical significance, but for the purpose of diagnostic accuracy study, our gold standard is that of an accepted reference test now in use in routine clinical practice. Second, although studies were analyzed in a blinded 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 manner, it was noted that MBIR images have unique appearances, so complete blinding was difficult, nevertheless steps were made to present image datasets in a randomized manner and all identifiable information removed. Third, we set out to examine differences between automatic tube current modulation and fixed current approaches. We did not alter protocols based on BMI but results from this work will give guidance to future studies that may incorporate BMI into protocols. Fourth, we acknowledged that the study design requires an increase in radiation exposure to the patient, but the incremental increase was on average around 33% increase from average dose, and this was deemed acceptable from our ethics board of approval.
Conclusion:
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